In this is a multi-site descriptive study Dr. Rosenzweig and her team will compare the chemotherapy symptom experience, management and dose intensity received/prescribed according to race. Genetics, epigenetics, and pharmacogenomics are areas of further exploration. Click here for more information.
(Funding Source: NIH/NIMHD Grant R01MD012245)
Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity